Results 121 to 130 of about 9,178 (213)
Glioblastoma (GBM) is the most common and deadly primary malignant brain tumor. Current therapies are insufficient, and survival for individuals diagnosed with GBM is limited to a few months. New GBM treatments are urgent.
Ana Alves +10 more
doaj +1 more source
Mian Wang,1 Benjamin M Geilich,2 Michael Keidar,3 Thomas J Webster1,4 1Department of Chemical Engineering, 2Department of Bioengineering, Northeastern University, Boston, MA, 3Department of Mechanical and Aerospace Engineering, George Washington ...
Wang M, Geilich BM, Keidar M, Webster TJ
doaj
Strategies to deliver peptide drugs to the brain [PDF]
Lalatsa, Katerina +2 more
core +1 more source
Tingting Jia,1,* Zhiguo Sun,1,* Ying Lu,1 Jie Gao,1 Hao Zou,1 Fangyuan Xie,2 Guoqing Zhang,2 Hao Xu,3 Duxin Sun,3 Yuan Yu,1 Yanqiang Zhong1 1Department of Pharmaceutical Sciences, School of Pharmacy, The Second Military Medical University, 2Department ...
Jia TT +10 more
doaj
Polymersome-based nanomedicine for combined cancer therapy. [PDF]
Mohammadi Zonouz A +7 more
europepmc +1 more source
Butyrylcholinesterase-Loaded Liposomes and Polymersomes: Catalytic Parameters for Three Types of Substrates. [PDF]
Shaihutdinova Z +3 more
europepmc +1 more source
Leaky by Design: Unlocking Polymersome Permeability Using Moderately Hydrophobic Polymer Blocks. [PDF]
Zhang W +8 more
europepmc +1 more source
Functionalized nanozyme delivery of a KCC2-activator conjugate for the promotion of functional recovery after acute spinal cord injury. [PDF]
Zhao H +5 more
europepmc +1 more source
Activating PEG host to enable spatially controlled surface functionalization of nanocarriers for biomedical applications. [PDF]
Sun M, Li W, Zhang S, Wilson DA.
europepmc +1 more source

